PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Savara Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Savara Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than almost all Healthcare companies in United States.
  • Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 97% of Healthcare companies in United States.
  • Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Data incomplete

Self-Funding Ratio

-703.2×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 97% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

0/3 · 0/3

Sales and profit both fell in each of the last 3 years.

Less steady than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

-14,433.9×

Operating cash was negative last year, while some debt falls due within a year.

Lower than almost all Healthcare companies in United States.

Cash Cushion Ratio

+22%

Cash, after subtracting all debt, equals 22% of its market value (net cash).

Higher than 64% of Healthcare companies in United States.

Tangible Assets Ratio

95%

Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 74% of Healthcare companies in United States.

Tangible Net Worth Ratio

94%

Of every $100 of net worth, $94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 79% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+79%

Share count rose 79% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 64% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (10)

Savara Inc. made a loss over the last year. Savara Inc. owes $0.25 for every $1 it owns. Savara Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Savara Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

6.04

The share price is 6.04 times Savara Inc.'s book value per share, higher than 76% of Healthcare companies in United States.

Market cap

$867 M

The total market value of all of Savara Inc.'s shares at today's price (share price × number of shares), larger than 62% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$144 M

What Savara Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.70

Net worth divided by the number of shares. The share price of $4.22 is 6.0 times this, which is the P/B above.

Return on equity (ROE)

-105.5%

Savara Inc. lost 105.5% of its shareholders' money over the last year, lower than 72% of Healthcare companies in United States.

Owes vs Owns

0.25×

Savara Inc. owes $0.25 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.

Dividend yield

None

Savara Inc. does not currently pay a dividend.

Profit growth

Loss

Savara Inc. made a loss in each of the last two years.

Cash vs debt

Net cash

Savara Inc. held $206 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Savara Inc.: $867 M ÷ $144 M (30 Jun 2026) = 6.0.

What is Savara Inc.'s return on equity?

Savara Inc. lost 105.5% of its shareholders' money over the last year, lower than 72% of Healthcare companies in United States.

How much does Savara Inc. owe compared with what it owns?

Savara Inc. owes $0.25 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.

Does Savara Inc. pay a dividend?

No. Savara Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.